Series B Funded Startups in Denmark
Series B rounds in Denmark (14 rows) cluster in a tight Copenhagen-area geography while amounts show a clear size split.
Series B rounds in Denmark (14 rows) cluster in a tight Copenhagen-area geography while amounts show a clear size split. On the size axis, ADCendo’s $135M (2024-11-25) is the only disclosed round above $120M, and it ties the top tier again with Hemab’s $135M (2023-02-21); everything else sits below that level, with a next tier around the $60M range (e.g., Corti $60M on 2023-09-20 and Podimo $59M on 2022-09-14).
Sector-wise, Biotechnology is the most repeated category with 4 entries (SNIPR Biome $41M on 2025-08-07, ADCendo $135M on 2024-11-25, Acesion Pharma $48M on 2023-09-26, Hemab $135M on 2023-02-21, plus Biosyntia $12M on 2022-07-06), while AI appears 3 times (Dreamdata $55M on 2025-10-18, Corti $60M on 2023-09-20, Leapwork $62M on 2021-08-25). Temporally, the covered window runs from 2021-08-25 (Leapwork) through 2025-10-28 (Formalize), with a concentrated run of Copenhagen-based rounds in 2024–2025 (e.g., Dreamdata, SNIPR Biome, ADCendo, Monta, Flatpay).
Most recent rounds
14 shownRelated listings
Frequently asked
Which disclosed round is the size outlier in Denmark Series B, and what happens to the rest of the list’s amounts afterward?
ADCendo’s $135M (2024-11-25) is the largest disclosed amount shown; Hemab also discloses $135M (2023-02-21), so $135M is the ceiling in this slice. After that top tier, the next-largest disclosed amounts drop notably (e.g., Monta $87M on 2024-01-23 and Leapwork $62M on 2021-08-25).
Do the most recent Denmark Series B closings cluster by city, or are they spread across locations?
Copenhagen-area locations dominate: the majority of entries list Copenhagen (e.g., Dreamdata $55M on 2025-10-18; SNIPR Biome $41M on 2025-08-07; Corti $60M on 2023-09-20; Podimo $59M on 2022-09-14), with additional nearby municipalities also appearing (Herlev: Flatpay $48M on 2024-04-17; Hørsholm: Biosyntia $12M on 2022-07-06; Ballerup: Norlase $10M on 2021-10-26).
Which companies closed within the most recent 90 days of the latest date shown, and do they share any sector pattern?
Using the latest row date, 2025-10-28, the 90-day window includes 2025-08-07 (SNIPR Biome $41M, Biotechnology), 2025-10-18 (Dreamdata $55M, AI). Within this window, sectors split across AI and Biotechnology rather than concentrating in a single category.
What sector mix dominates these Denmark Series B rounds, based on how often each sector appears in the 14 rows?
Biotechnology is the most frequent sector with 4 entries (SNIPR Biome $41M on 2025-08-07; ADCendo $135M on 2024-11-25; Acesion Pharma $48M on 2023-09-26; Hemab $135M on 2023-02-21; Biosyntia $12M on 2022-07-06 also falls under Biotechnology as shown). AI appears 3 times (Dreamdata $55M on 2025-10-18; Corti $60M on 2023-09-20; Leapwork $62M on 2021-08-25).
Are there notably small disclosed rounds that stand out against the rest of the distribution?
Yes. Biosyntia’s $12M (2022-07-06) and Norlase’s $10M (2021-10-26) sit near the bottom of the disclosed amounts, while many other rounds cluster far higher (e.g., ADCendo and Hemab at $135M; Monta $87M on 2024-01-23; Corti $60M on 2023-09-20).
What are the temporal edges of this Series B Denmark snapshot, and what does the run-up to the latest date suggest about recency concentration?
The earliest disclosed round in the shown rows is Leapwork on 2021-08-25 ($62M), and the most recent is Formalize on 2025-10-28 ($35M). Several rounds appear in the 2024–2025 period (e.g., Dreamdata 2025-10-18 $55M; SNIPR Biome 2025-08-07 $41M; ADCendo 2024-11-25 $135M; Monta 2024-01-23 $87M), indicating recency concentration rather than evenly spaced years.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.